Evidence map›Paper›PMID 27145342›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2016

Role of Bone Marrow Maturity, Insulin-Like Growth Factor 1 Receptor, and Forkhead Box Protein N1 in Thymic Involution and Rejuvenation.

M Tasaki, V Villani, A Shimizu, M Sekijima, R Yamada, I M Hanekamp, J S Hanekamp, T A Cormack, S G Moran, A Kawai and 2 more

Open access · hybridAbstract read
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Thymus Degeneration and Regeneration.Frontiers in immunology · 2021
    Review
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

M TasakiTransplantation Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
V VillaniTransplantation Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
A ShimizuTransplantation Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
M SekijimaTransplantation Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
R YamadaTransplantation Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
I M HanekampTransplantation Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
J S HanekampTransplantation Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
T A CormackTransplantation Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
S G MoranTransplantation Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
A KawaiTransplantation Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
D H SachsTransplantation Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
K YamadaTransplantation Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
Massachusetts General Hospital · USHarvard University · US

Funding

XENOGRAFT TOLERANCE THROUGH MIXED CHIMERISMP01AI045897 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Megan Sykes · 2000 to 2026
$71.9M
TOLERANCE TO VASCULARIZED ALLOGRAFTS IN MINISWINER37AI031046 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI SACHS, DAVID H · 2006 to 2015
$7.3M
TOLERANCE TO VASCULARIZED ALLOGRAFTS IN MINISWINER01AI031046 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI SACHS, DAVID H · 1991 to 2005
$3.3M
RES FACIL CONST: XENOTRANSPLANTATION, LUNG ALLOGRAFT REJECTION IN SWINEC06RR020135 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI SLAVIN, PETER L · 2004 to 2004
$2.7M
Thymic Rejuvenation for the Induction of Transplantation ToleranceR01AI086134 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI SACHS, DAVID H, YAMADA, KAZUHIKO · 2010 to 2014
$2.1M
NCRR NIH HHS C06 RR020135NIAID NIH HHS P01 AI045897NIAID NIH HHS R01 AI031046NIAID NIH HHS R01 AI086134NIAID NIH HHS R37 AI031046
6 · The paper itself

Abstract

Thymic involution is associated with age-related changes of the immune system. Utilizing our innovative technique of transplantation of a thymus as an isolated vascularized graft in MHC-inbred miniature swine, we have previously demonstrated that aged thymi are rejuvenated after transplantation into juvenile swine. Here we have studied the role of insulin-like growth factor (IGF) and forkhead-box protein-N1 (FOXN1) as well as bone marrow (BM) in thymic rejuvenation and involution. We examined thymic rejuvenation and involution by means of histology and flow cytometry. Thymic function was assessed by the ability to induce tolerance of allogeneic kidneys. Aged thymi were rejuvenated in a juvenile environment, and successfully induced organ tolerance, while juvenile thymi in aged recipients involuted and had a limited ability to induce tolerance. However, juvenile BM inhibited the involution process of juvenile thymi in aged recipients. An elevated expression of both FOXN1 and IGF1 receptors (IGF-1R) was observed in juvenile thymi and rejuvenated thymi. Juvenile BM plays a role in promoting the local thymic milieu as indicated by its ability to inhibit thymic involution in aged animals. The expression of FOXN1 and IGF-1R was noted to increase under conditions that stimulated rejuvenation, suggesting that these factors are involved in thymic recovery.

Indexed as

AgingAnimalsBone MarrowCell DifferentiationForkhead Transcription FactorsGraft SurvivalImmune ToleranceReceptor, IGF Type 1RejuvenationSwineSwine, MiniatureThymus GlandForkhead Transcription FactorsReceptor, IGF Type 1Whn proteinanimal models: porcinebasic (laboratory) research/sciencebone marrow/hematopoietic stem cell transplantationimmunobiologykidney transplantation/nephrologythymus/thymic biologytolerance: experimentaltranslational research/science

Identifiers

PMID27145342
PMCPMC5097038
OpenAlexW2346216198

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.